Neuralink is a Biotech company based in Fremont, California. It has raised $1.3B in total funding. Latest round: Series E.
Neuralink funding overview
Neuralink is a Biotech company based in Fremont, California. Neuralink has raised $1.3B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is a Series E announced in June 2025. The round record for Neuralink runs through 2025; nothing later has been disclosed. Investors on record include ARK Invest, DFJ Growth, Founders Fund, G42, Human Capital, Lightspeed and 5 others. 11 distinct backers are named across the disclosed rounds.
Neuralink at a glance
Total raised
$1.3B
Latest round
Series E
Latest round date
June 2025
Industry
Biotech
Headquarters
Fremont, California
Notable investors
ARK Invest, DFJ Growth, Founders Fund, G42, Human Capital, Lightspeed, QIA, Sequoia Capital
Frequently asked about Neuralink funding
How much has Neuralink raised?
Neuralink has raised $1.3B in total disclosed funding across the rounds on record.
Who has invested in Neuralink?
ARK Invest, DFJ Growth, Founders Fund, G42, Human Capital, Lightspeed are named among the investors backing Neuralink.
What was the latest Neuralink funding round?
The most recent disclosed round is a Series E, announced in June 2025.
Where is Neuralink based?
Neuralink is based in Fremont, California.
What sector does Neuralink operate in?
Neuralink is tracked under Biotech from Fremont, California, with $1.3B in disclosed funding.
When did Neuralink last raise?
The last disclosed Neuralink round closed in June 2025 at Series E.
Totals shown for Neuralink aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Fremont and the investors behind them below.
